ARTICLE | Clinical News
Interferon Alpha-2b: Phase II start
September 19, 2005 7:00 AM UTC
HBP will start a double-blind, placebo-controlled, Swedish Phase II trial. The company said it would begin the trial in concert with raising additional required capital, but did not provide guidance o...